Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-8117.81%
operating margin TTM
-3548.44%
revenue TTM
-18.30 Thousand
revenue per share TTM
-0.0$
valuation ratios | |
|---|---|
| pe ratio | -0.00 |
| peg ratio | 0.00 |
| price to book ratio | 0.00 |
| price to sales ratio | 0.01 |
| enterprise value multiple | -0.09 |
| price fair value | 0.00 |
profitability ratios | |
|---|---|
| gross profit margin | 32.44% |
| operating profit margin | -3548.44% |
| pretax profit margin | -8117.81% |
| net profit margin | -8117.81% |
| return on assets | -552.88% |
| return on equity | -274.69% |
| return on capital employed | -284.27% |
liquidity ratios | |
|---|---|
| current ratio | 4.51 |
| quick ratio | 2.62 |
| cash ratio | 1.74 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 2,245.48 |
| operating cycle | 2,445.16 |
| days of payables outstanding | 628.20 |
| cash conversion cycle | 1,816.96 |
| receivables turnover | 1.83 |
| payables turnover | 0.58 |
| inventory turnover | 0.16 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.10 |
| debt equity ratio | 0.12 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.11 |
| interest coverage | -152.94 |
| cash flow to debt ratio | -20.23 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.86 |
| cash per share | 0.25 |
| operating cash flow per share | -1.84 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -20.23 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -76.40 |
Frequently Asked Questions
When was the last time HAVN Life Sciences Inc. (PNK:HAVLF) reported earnings?
HAVN Life Sciences Inc. (HAVLF) published its most recent earnings results on 31-10-2023.
What is HAVN Life Sciences Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. HAVN Life Sciences Inc. (PNK:HAVLF)'s trailing twelve months ROE is -274.69%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. HAVN Life Sciences Inc. (HAVLF) currently has a ROA of -552.88%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did HAVLF's net profit margin stand at?
HAVLF reported a profit margin of -8117.81% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is HAVLF's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.51 in the most recent quarter. The quick ratio stood at 2.62, with a Debt/Eq ratio of 0.12.